Near Infrared Light Treatment Reduces Synaptic Levels of Toxic Tau Oligomers in Two Transgenic Mouse Models of Human Tauopathies

[1]  C. Dobson,et al.  Hsp70 Inhibits the Nucleation and Elongation of Tau and Sequesters Tau Aggregates with High Affinity , 2018, ACS chemical biology.

[2]  David W. Colby,et al.  Inert and seed-competent tau monomers suggest structural origins of aggregation , 2017, bioRxiv.

[3]  G. Taglialatela,et al.  Near infrared light decreases synaptic vulnerability to amyloid beta oligomers , 2017, Scientific Reports.

[4]  J. Götz,et al.  Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn‐mediated local protein translation , 2017, The EMBO journal.

[5]  Shelby Meier,et al.  TAU OLIGOMERS MEDIATE RIBOSOMAL DYSFUNCTION AT THE SYNAPSE , 2017, Alzheimer's & Dementia.

[6]  Rosemary J. Jackson,et al.  Tau association with synaptic vesicles causes presynaptic dysfunction , 2017, Nature Communications.

[7]  G. Krasnov,et al.  Molecular Mechanisms Underlying Neuroprotective Effect of Intranasal Administration of Human Hsp70 in Mouse Model of Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.

[8]  G. Carlson,et al.  Stabilizing the Hsp70-Tau Complex Promotes Turnover in Models of Tauopathy. , 2016, Cell chemical biology.

[9]  D. Bennett,et al.  NMNAT2:HSP90 Complex Mediates Proteostasis in Proteinopathies , 2016, PLoS biology.

[10]  G. Taglialatela,et al.  A method to determine insulin responsiveness in synaptosomes isolated from frozen brain tissue , 2016, Journal of Neuroscience Methods.

[11]  A. Palmeri,et al.  Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory , 2016, Scientific Reports.

[12]  J. Renger,et al.  Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells , 2015, The Journal of Neuroscience.

[13]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[14]  E. Mandelkow,et al.  Lost after translation: missorting of Tau protein and consequences for Alzheimer disease , 2014, Trends in Neurosciences.

[15]  W. H. Yu,et al.  Promoting Autophagic Clearance: Viable Therapeutic Targets in Alzheimer’s Disease , 2014, Neurotherapeutics.

[16]  B. Hyman,et al.  Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer’s disease , 2014, Acta Neuropathologica Communications.

[17]  R. Leak.  Heat shock proteins in neurodegenerative disorders and aging , 2014, Journal of Cell Communication and Signaling.

[18]  R. Swerdlow,et al.  The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. , 2014, Biochimica et biophysica acta.

[19]  L. Grinberg,et al.  Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies , 2014, Neuron.

[20]  U. Sengupta,et al.  Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds. , 2014, Journal of Alzheimer's disease : JAD.

[21]  J. Stone,et al.  Photobiomodulation with near infrared light mitigates Alzheimer’s disease-related pathology in cerebral cortex – evidence from two transgenic mouse models , 2014, Alzheimer's Research & Therapy.

[22]  S. Oddo,et al.  Autophagic/lysosomal dysfunction in Alzheimer’s disease , 2013, Alzheimer's Research & Therapy.

[23]  A. Vortmeyer,et al.  Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein , 2013, Neuron.

[24]  A. Ennaceur,et al.  Non-invasive infra-red therapy (1072 nm) reduces β-amyloid protein levels in the brain of an Alzheimer's disease mouse model, TASTPM. , 2013, Journal of photochemistry and photobiology. B, Biology.

[25]  V. Uversky,et al.  Imbalance of Hsp70 family variants fosters tau accumulation , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  U. Sengupta,et al.  Identification of oligomers at early stages of tau aggregation in Alzheimer's disease , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  H. Parri,et al.  Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease. , 2011, Biochemical pharmacology.

[28]  U. Sengupta,et al.  Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice , 2011, Molecular Neurodegeneration.

[29]  Luis De Taboada,et al.  Transcranial laser therapy attenuates amyloid-β peptide neuropathology in amyloid-β protein precursor transgenic mice. , 2011, Journal of Alzheimer's disease : JAD.

[30]  R. Kayed,et al.  Preparation and characterization of neurotoxic tau oligomers. , 2010, Biochemistry.

[31]  G. Taglialatela,et al.  Amyloid‐β oligomers impair fear conditioned memory in a calcineurin‐dependent fashion in mice , 2010, Journal of neuroscience research.

[32]  D. Wilcock,et al.  Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease , 2010, Neuroscience.

[33]  T. Karu,et al.  Mitochondrial mechanisms of photobiomodulation in context of new data about multiple roles of ATP. , 2010, Photomedicine and laser surgery.

[34]  N. Mizushima,et al.  Methods in Mammalian Autophagy Research , 2010, Cell.

[35]  Jürgen Götz,et al.  Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia , 2008, Proceedings of the National Academy of Sciences.

[36]  Bernardo L Sabatini,et al.  Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway , 2007, The Journal of Neuroscience.

[37]  S. Maeda,et al.  Increased levels of granular tau oligomers: An early sign of brain aging and Alzheimer's disease , 2006, Neuroscience Research.

[38]  A. Delacourte,et al.  Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease , 1990, Acta Neuropathologica.

[39]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[40]  P. Davies,et al.  Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms , 2003, Journal of neurochemistry.

[41]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[42]  J. Morrison,et al.  Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease , 2003, Neurology.

[43]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[44]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[45]  C. Patterson,et al.  Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling , 2001, Current Biology.

[46]  P. Davies,et al.  Characterization of Pathology in Transgenic Mice Over-Expressing Human Genomic and cDNA Tau Transgenes , 2000, Neurobiology of Disease.

[47]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.